Press Releases

GlobeNewswire, Inc.

TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, will release its third...

EIN Presswire

WHE 2026 unites global hydrogen leaders to drive investment, commercialization, trade and clean hydrogen innovation.

EIN Presswire

The company behind HalloBatumi.de is expanding its focus toward integrated developments that combine property ownership & additional commercial revenue sources.

MENAFN

(MENAFN) Germany held commemorative events on Wednesday marking 15 years since the discovery of the neo-Nazi terrorist organization National Socialist Underground (NSU), as renewed demands emerged for a more comprehensive examination of its...

MENAFN

(MENAFN) The European Commission convened high-stakes talks on Wednesday with Ukraine and its international partners, aiming to chart Kyiv’s post-war economic recovery and lock in a durable peace.

MENAFN

(MENAFN) German Vice Chancellor Lars Klingbeil congratulated the US Democratic Party on its “landslide victory” in the midterm elections on Wednesday, describing the outcome as a source of renewed confidence, according to reports. “This certainly...

MENAFN

(MENAFN) Proposed changes to Germany's housing benefit system could place additional financial pressure on vulnerable households, potentially cutting off both rental assistance and access to food banks and subsidized social stores, according to...

GlobeNewswire, Inc.

Topline data from 400-person sentinel safety cohort and approximately 5,000 patients in main cohort Phase 2b COVID-19 trial anticipated by mid-year 2027 Expanded intellectual property portfolio with new European patent that further protects core...

GlobeNewswire, Inc.

WOODBURY, N.Y., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its third quarter of 2026. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial...

GlobeNewswire, Inc.

Cash and cash equivalents of €95.6 million as of September 30, 2026; expected to fund the Company beyond 2028, with continued revenue growth and disciplined spending thereafter expected to drive GENFIT toward profitability €36.3 million in revenue...

EIN Presswire

Biggest rise in the income threshold for private health insurance since 2003; the maximum public health and long-term care contribution rises to €1,345 a month BIELEFELD, NRW, GERMANY, November 5, 2026 /⁨EINPresswire.com⁩/ -- Employees in Germany...

GlobeNewswire, Inc.

NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Thursday, November 12, 2026, featuring live webcast presentations from international...

GlobeNewswire, Inc.

Successful satellite launch, key regulatory approvals, and strong Commercial IoT device sales highlight third-quarter achievements Generated third quarter 2026 revenue of $70.9 million with another quarter of strong Commercial IoT subscriber...

GlobeNewswire, Inc.

AUSTIN, Texas, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC), the open commerce ecosystem built to help merchants win as AI reshapes how customers discover and buy, today announced financial results for its third quarter...

GlobeNewswire, Inc.

Worldwide revenue of $389.9 million in the third quarter of 2026 GAAP fully diluted earnings per share of $0.33, compared to $0.41 in the third quarter of 2025 Adjusted fully diluted earnings per share of $1.68, compared to $1.27 in the third...

GlobeNewswire, Inc.

PRINCETON, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being...

GlobeNewswire, Inc.

Completed Statistical Analyses of LEVEL Yielded a Predictive Enrichment Strategy Being Applied in Amended LEVEL-2 Protocol Company Has Been Granted a Type C Meeting with the FDA CHAPEL HILL, N.C., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Tenax...

GlobeNewswire, Inc.

Cemsidomide Phase 2 MOMENTUM Trial On Track to Complete Enrollment in 1Q 2027 with Initial ORR Data Expected in 2H 2027 Enrollment Complete for First Safety Cohort in Phase 1b Trial of Cemsidomide with Elranatamab; Progressing Additional Cohorts...

GlobeNewswire, Inc.

Four autonomous, electric vehicles to handle key in-plant transport at Lorenz’s site in Neunburg vorm Wald, Germany.

GlobeNewswire, Inc.

MYQORZO® (aficamten) Net Product Revenue of $44.5 Million Expect to Submit Supplemental NDA for Aficamten in Non-Obstructive HCM in Q4 2026 and Type II Variation in the European Union in Early 2027 ~$1.6 Billion in Cash, Cash Equivalents and...